What companies are URGN's competitors?

UroGen Pharma Ltd. (URGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does URGN compare to its peers?

The peer comparison table on this page shows UroGen Pharma Ltd. (URGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does URGN operate in?

UroGen Pharma Ltd. (URGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

URGN

UroGen Pharma Ltd.

NASDAQ·Biotechnology · Healthcare

$43.78$2.66+6.47%

After hours·$43.91+0.30%

Market cap$2.13B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About URGN

What companies are URGN's competitors?: UroGen Pharma Ltd. (URGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does URGN compare to its peers?: The peer comparison table on this page shows UroGen Pharma Ltd. (URGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does URGN operate in?: UroGen Pharma Ltd. (URGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

URGN

UroGen Pharma Ltd.

NASDAQ·Biotechnology · Healthcare

$43.78$2.66+6.47%

After hours·$43.91+0.30%

Market cap$2.13B·Market closed·Jul 21 8:00 PM UTC

Peers


TNGX	Tango Therapeutics, Inc.	$29.02	$3.6B
ANAB	AnaptysBio, Inc.	$53.76	$2.3B
KOD	Kodiak Sciences Inc.	$42.42	$2.2B
NRIX	Nurix Therapeutics, Inc.	$23.48	$2.0B
MNMD	Mind Medicine (MindMed) Inc.	$20.69	$1.6B
XNCR	Xencor, Inc.	$20.45	$1.5B
PHAT	Phathom Pharmaceuticals, Inc.	$11.25	$897.3M
BBOT	BridgeBio Oncology Therapeutics Inc.	$8.72	$698.5M
OCS	Oculis Holding AG	$11.96	$683.7M
PROK	ProKidney Corp.	$1.60	$536.3M

Frequently Asked Questions About URGN

What companies are URGN's competitors?: UroGen Pharma Ltd. (URGN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does URGN compare to its peers?: The peer comparison table on this page shows UroGen Pharma Ltd. (URGN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does URGN operate in?: UroGen Pharma Ltd. (URGN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.